DB06256InvestigationalProtein Based Therapies
Recombinant P-selectin glycoprotein ligand IgG fusion protein (rPSGL-Ig) is a fusion protein of human P-selectin ligand and IgG1-Fc.
- Mechanism
- Curator reviewed
Pharmacologically active on E-selectin and P-selectin
- Primary indication
- Investigated for use/treatment in myocardial infarction, red blood cell disorders, anemia, kidney transplant surgery, transplant (rejection), liver transplant surgery, and ischemic reperfusion injury.Curator reviewed
- Also known as
- Recombinant P-selectin glycoprotein ligand-immunoglobulin Ig · Recombinant soluble PSGL-1 Fc chimera · rPSGL-1-Ig · YSPSL
Resolves to
Targets
What you can answer from here — as of July 03, 2026
Which drugs share a target with rPSGL-Ig, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account